p53 Changes in Ovarian Cancer and Their Impact on Treatment
Author Information
Author(s): F Buttitta, A Marchetti, A Gadducci, S Pellegrini, M Morganti, V Carnicelli, S Cosio, O Gagetti, AR Genazzani, G Bevilacqua
Primary Institution: University of Pisa
Hypothesis
The study investigates the prognostic and predictive role of p53 alterations in ovarian cancer.
Conclusion
Tumours with p53 alterations are less sensitive to chemotherapy and more aggressive than those with functional p53.
Supporting Evidence
- p53 alterations were found only in invasive ovarian carcinomas, not in low malignant potential tumours.
- Patients with p53 mutations had a significantly shorter progression-free survival.
- Only 14% of patients with a complete response to chemotherapy had p53 aberrations.
Takeaway
This study found that changes in a gene called p53 can make ovarian cancer harder to treat and more dangerous.
Methodology
The study analyzed 68 ovarian neoplasms using genetic and immunohistochemical analyses to evaluate p53 alterations.
Limitations
The study's sample size is relatively small, and it focuses only on epithelial ovarian malignancies.
Participant Demographics
Patients aged 41-81 years, median age 59.
Statistical Information
P-Value
p=0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website